 REDWOOD CITY, CA ACCESSWIRE June 7, 2021 Avinger, Inc. NASDAQ:AVGR, a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease PAD, today announced two podium presentations featuring the companys Lumivascular technology at the New Cardiovascular Horizons NCVH annual conference, which took place June 1 through June 4 in New Orleans. Key opinion leaders in the fields of interventional cardiology and endovascular interventions highlighted Avingers Lumivascular technology in the following sessions: Dr. Jon George, an interventional cardiologist and endovascular medicine specialist at Pennsylvania Hospital, University of Pennsylvania Health System in Philadelphia, included Avingers proprietary OCT-guided platform in his session, Are Intravascular Ultrasound and OCT Being Utilized Enough in Peripheral Interventions? 